EAM
Erste Asset Management Portfolio holdings
AUM
$11.9B
1-Year Return
22.95%
This Quarter Return
+7.94%
1 Year Return
+22.95%
3 Year Return
+112.82%
5 Year Return
+205.55%
10 Year Return
–
AUM
$4.09B
AUM Growth
+$472M
(+13%)
Cap. Flow
+$286M
Cap. Flow
% of AUM
6.99%
Top 10 Holdings %
Top 10 Hldgs %
16.99%
Holding
924
New
29
Increased
201
Reduced
78
Closed
20
Top Buys
| 1 |
Sarepta Therapeutics
SRPT
|
$19.5M |
| 2 |
Applied Materials
AMAT
|
$18.9M |
| 3 |
Parker-Hannifin
PH
|
$17M |
| 4 |
NVIDIA
NVDA
|
$15.7M |
| 5 |
VMW
VMware, Inc
VMW
|
$15.1M |
Top Sells
| 1 |
ON Semiconductor
ON
|
$45.8M |
| 2 |
Tapestry
TPR
|
$12.4M |
| 3 |
Blackrock
BLK
|
$11.6M |
| 4 |
Intercontinental Exchange
ICE
|
$10.6M |
| 5 |
Amphenol
APH
|
$10.4M |
Sector Composition
| 1 | Technology | 27.94% |
| 2 | Healthcare | 19.38% |
| 3 | Consumer Discretionary | 15.8% |
| 4 | Industrials | 10.12% |
| 5 | Financials | 8.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
351
Intellia Therapeutics
NTLA
$1.29B
| $708K | 0.02% |
9,800
-7,800
| -44% | -$563K |
|
352
Steel Dynamics
STLD
$19.8B
| $703K | 0.02% |
13,700
| – | – |
|
353
FMC
FMC
$4.72B
| $701K | 0.02% |
6,339
+2,485
| +64% | +$275K |
|
354
Schlumberger
SLB
$53.4B
| $700K | 0.02% |
25,700
-25,700
| -50% | -$700K |
|
|
ITCI
355
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $683K | 0.02% |
21,000
| – | – |
|
356
KALA BIO
KALA
$102M
| $672K | 0.02% |
2,102
| – | – |
|
357
Avery Dennison
AVY
$13.1B
| $667K | 0.02% |
3,600
| – | – |
|
|
AUTL
358
Autolus Therapeutics
AUTL
$389M
| $659K | 0.02% |
+120,000
| New | +$659K |
|
359
Coca-Cola
KO
$292B
| $659K | 0.02% |
12,434
| – | – |
|
360
Pembina Pipeline
PBA
$22.1B
| $643K | 0.02% |
22,400
+3,000
| +15% | +$86.1K |
|
361
Ligand Pharmaceuticals
LGND
$3.25B
| $641K | 0.02% |
6,893
| – | – |
|
362
Arthur J. Gallagher & Co
AJG
$76.7B
| $641K | 0.02% |
5,100
| – | – |
|
|
QIWI
363
DELISTED
QIWI PLC
QIWI
| $639K | 0.02% |
60,000
| – | – |
|
364
Arvinas
ARVN
$575M
| $638K | 0.02% |
10,200
| – | – |
|
365
B2Gold
BTG
$5.52B
| $632K | 0.02% |
146,758
+70,129
| +92% | +$302K |
|
366
ALX Oncology
ALXO
$65.3M
| $629K | 0.02% |
9,200
| – | – |
|
367
F5
FFIV
$18.1B
| $623K | 0.02% |
3,000
| – | – |
|
368
Freeport-McMoran
FCX
$66.5B
| $622K | 0.02% |
19,000
| – | – |
|
369
TC Energy
TRP
$53.9B
| $609K | 0.01% |
13,100
| – | – |
|
370
iShares MSCI Australia ETF
EWA
$1.53B
| $583K | 0.01% |
+23,500
| New | +$583K |
|
371
Kinder Morgan
KMI
$59.1B
| $565K | 0.01% |
34,000
-16,000
| -32% | -$266K |
|
372
MacroGenics
MGNX
$126M
| $560K | 0.01% |
18,000
| – | – |
|
373
Twist Bioscience
TWST
$1.55B
| $549K | 0.01% |
5,000
-6,900
| -58% | -$757K |
|
374
Seres Therapeutics
MCRB
$169M
| $525K | 0.01% |
1,350
| – | – |
|
|
375
ON Semiconductor
ON
$20.1B
| $518K | 0.01% |
12,460
-1,100,000
| -99% | -$45.8M |
|